Clinical Trials
3 trialsNCT03033992 2026-06-02
Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG
Children's Oncology Group
Phase NA Active not recruiting
NCT04903080 2026-06-02
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
Children's Oncology Group
Phase 1 Active not recruiting
NCT04978727 2026-06-02
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Children's Oncology Group
Phase 1 Active not recruiting